Blood test that can detect breast cancer available in India now, know the cost

Image Source: FREEPIK

image representing blood test

A blood test has been made available in India that is proven to detect breast cancer at an early stage. The test is available in more than 15 countries around the world and can detect stage 0 and stage 1 breast cancer in women with 99 percent accuracy. According to reports, the blood test can help detect early-stage breast cancer for those over the age of 40.

Cost in India

The test, which is branded as EasyCheck Breast, costs Rs 6,000. It was approved by the U.S. Food and Drug Administration last November and is indicated as an annual test for healthy women over the age of 40 who may not have any symptoms. The study found that stage 0 and stage 1 breast cancers were detected with 99 percent accuracy.

Read: Men’s Health Month: Prostate Cancer in Younger Men on the Rise, Knowing Early Signs, Treatment

Blood tests to help women detect breast cancer

“It’s not a replacement for mammograms, but women who test positive for breast cancer using the new technology can undergo conventional screening tests and have a biopsy right away and plan their treatment for cancer,” said a doctor, who further suggested that if If a woman tests negative, she must also undergo other screening tests to rule out breast cancer completely.

Gene drug that improves the survival rate of breast cancer patients

Meanwhile, the results of a study published in the journal Lancet Oncology showed that the breast cancer patients who received Capivasertib, developed by AstraZeneca, survived nearly twice as long as those who received only the standard treatment. “There has never been a trial targeting this genetic pathway in breast cancer that has an overall survival benefit like this — it’s really very special,” said Prof. Rob Jones of Velindre Cancer Center and Cardiff University.

Read: Not Just Moms, But Postpartum Depression Affects Dads Too

(With input from news agencies)

Leave a Comment

Your email address will not be published.